Related Experiment Video
Updated: May 4, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Clustering gene expression regulators: new approach to disease subtyping
Mikhail Pyatnitskiy1, Ilya Mazo2, Maria Shkrob3
1Institute of Biomedical Chemistry, RAMS, Moscow, Russia ; Ariadne Diagnostics LLC, Rockville, Maryland, United States of America.
This study introduces a new method for patient stratification using gene expression regulators. The Sub-Network Enrichment Analysis (SNEA) algorithm groups patients based on molecular mechanisms, improving personalized medicine and disease understanding.
Area of Science:
- Computational Biology
- Genomics
- Systems Biology
Background:
- Personalized medicine requires patient stratification based on molecular mechanisms.
- Current methods may not fully capture pathway-level biological differences.
Purpose of the Study:
- To develop a novel method for disease subtyping using activated expression regulators.
- To enable personalized therapy by understanding patient-specific molecular mechanisms.
Main Methods:
- Utilized the Sub-Network Enrichment Analysis (SNEA) algorithm.
- Analyzed gene subnetworks, identified central regulators, and their downstream genes.
- Clustered regulators per patient and assigned activity scores for grouping.
Main Results:
- Demonstrated superior performance compared to existing methods.
- Successfully stratified neuromuscular disorders based on underlying causes.
- Differentiated colorectal carcinoma from adenoma by identifying key regulator clusters.
Conclusions:
- The SNEA approach offers a biologically meaningful feature selection method.
- Identifies significant expression regulators, enhancing pathway-level biological understanding.
- Facilitates hypothesis generation for molecular mechanisms driving clinical outcomes.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

